Search results for "GISTs"

showing 10 items of 102 documents

Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation

2018

Aim The impact of rate and rhythm control strategies on outcomes in patients with atrial fibrillation (AF) remains controversial. Our aims were: to report use of rate and rhythm control strategies in European patients from the EURObservational Research Program AF General Pilot Registry. Secondly, to evaluate outcomes according to assigned strategies. ........................................................................................................................................................... Methods and results Use of pure rate and rhythm control agents was described according to European regions. 1-year follow-up data were reported. Among rate control strategies, beta-blockers …

MaleTime FactorsRate controlAction PotentialsPilot Projects030204 cardiovascular system & hematologyAmiodaroneAction Potentials/drug effectsHeart Conduction System/drug effectsCardiologists0302 clinical medicineHeart RateRisk FactorsCause of DeathAtrial Fibrillation030212 general & internal medicineRegistriesPractice Patterns Physicians'Cause of deathAged 80 and overAll-cause death; Atrial fibrillation; Major adverse events; Rate control; Registry; Rhythm controlHeart Rate/drug effectsAtrial fibrillationMiddle AgedEuropeTreatment OutcomeCohortCardiologyHealthcare Disparities/trendsRhythm controlFemaleCardiology and Cardiovascular MedicineAnti-Arrhythmia AgentsCardiologists/trendsmedicine.drugmedicine.medical_specialtyMajor adverse eventsRegistryAll-cause deathAnti-Arrhythmia Agents/adverse effectsEurope/epidemiology03 medical and health sciencesHeart Conduction SystemPhysiology (medical)Internal medicineHeart ratemedicineAtrial Fibrillation/diagnosisHumansHealthcare DisparitiesAdverse effectAgedbusiness.industryProportional hazards modelmedicine.diseaseAtrial fibrillationPractice Patterns Physicians'/trendsAtrial fibrillation • Rate control • Rhythm control • Major adverse events • All-cause death • RegistryPropensity score matchingbusiness
researchProduct

Burnout in Cardiac Anesthesiologists: Results From a National Survey in Italy

2018

Objective There is increasing burnout incidence among medical disciplines, and physicians working in emergency settings seem at higher risk. Cardiac anesthesiology is a stressful anesthesiology subspecialty dealing with high-risk patients. The authors hypothesized a high risk of burnout in cardiac anesthesiologists. Design National survey conducted on burnout. Setting Italian cardiac centers. Participants Cardiac anesthesiologists. Interventions The authors administered via email an anonymous questionnaire divided into 3 parts. The first 2 parts evaluated workload and private life. The third part consisted of the Maslach Burnout Inventory test with its 3 constituents: high emotional exhaust…

Malehealth care facilities manpower and servicesPsychological interventionBurnoutstress0302 clinical medicine030202 anesthesiologyAnesthesiologystreDepersonalizationPrevalenceBurnout030212 general & internal medicineEmotional exhaustionBurnout Professionalemotional exhaustionIncidence (epidemiology)anesthesia; depersonalization; depression; emotional exhaustion; maslach burnout Inventory; personal accomplishment; stress; cardiology and cardiovascular medicine; anesthesiology and pain medicineWorkloadcardiology and cardiovascular medicineItalydepressionWorkforceFemalemedicine.symptompsychological phenomena and processesmedicine.medical_specialtyanesthesiology and pain medicineeducationCardiologyanesthesia depersonalization depression emotional exhaustion Maslach Burnout Inventory personal accomplishment stress Anesthesiologists Anesthesiology Burnout Professional Female Health Surveys Humans Italy Job Satisfaction Male Prevalence Workforce Workload CardiologyWorkloadanesthesiaSubspecialtyJob Satisfaction03 medical and health sciencesdepersonalizationhealth services administrationAnesthesiologyProfessionalmedicineHumansbusiness.industryanesthesia; depersonalization; depression; emotional exhaustion; Maslach Burnout Inventory; personal accomplishment; stressHealth SurveysAnesthesiologistsMaslach Burnout InventoryFamily medicinepersonal accomplishmentbusiness
researchProduct

The pathologist's role in the detection of rare variants of bladder cancer and analysis of the impact on incidence and type detection.

2018

BACKGROUND: Histology is one of the most important factors determining the prognosis of bladder cancers and rare variants are generally associated with decreased disease specific survival compared to pure transitional cell carcinomas. We believe that rare bladder cancer variants are likely underdiagnosed in the absence of a dedicated uro-pathologist in many centers. The objective of this study is to evaluate the contribution of a dedicated uro-pathologist on the identification of rare bladder cancer variants. METHODS: We retrospectively analyzed the clinical and histological records of all patients which underwent a radical cystectomy and lymph node dissection between January 2000 and Septe…

NephrologyMalemedicine.medical_specialtyPathologymedicine.medical_treatmentConcordanceUrology030232 urology & nephrologyCystectomyCystectomy03 medical and health sciences0302 clinical medicineProfessional RoleInternal medicineUrinary bladder neoplasmCarcinomaMedicineHumansCarcinoma transitional cell; Cystectomy; Urinary bladder neoplasms; Aged; Carcinoma Transitional Cell; Cystectomy; Female; Humans; Incidence; Lymph Node Excision; Male; Middle Aged; Professional Role; Retrospective Studies; Urinary Bladder Neoplasms; Pathologists; Nephrology; UrologyLymph nodeAgedRetrospective StudiesCarcinoma Transitional CellBladder cancerbusiness.industryIncidenceCarcinomaRetrospective cohort studyMiddle Agedmedicine.diseasePathologistsDissectionmedicine.anatomical_structureUrinary Bladder NeoplasmsNephrology030220 oncology & carcinogenesistransitional cellLymph Node ExcisionFemalebusinessMinerva urologica e nefrologica = The Italian journal of urology and nephrology
researchProduct

S3 Guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 2

2019

Epicutaneous patch testing is the diagnostic standard for the detection of allergic contact dermatitis. The present guidelines are aimed at residents and board-certified physicians in the fields of dermatology and allergology as well as other medical specialties involved in establishing the indication for patch testing and its execution in patients with contact dermatitis and other forms of delayed-type hypersensitivity. The target audience also includes other health care providers and insurance funds. Based on a systematic literature search and a formal consensus process (S3), the guidelines were developed by dermatologists in collaboration with pediatricians, occupational medicine physici…

Occupational Medicinemedicine.medical_specialtyConsensusMEDLINETarget audienceDermatologyOccupational medicineImmunocompromised Host030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePregnancyHealth caremedicineHumansHypersensitivity DelayedPediatriciansChildAdverse effectAllergic contact dermatitisbusiness.industryAllergensPatch Testsmedicine.disease3. Good healthTest (assessment)Family medicineDermatitis Allergic ContactPractice Guidelines as TopicFemaleNursing StaffbusinessContact dermatitisDermatologistsJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

S3 guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 1

2019

Epicutaneous patch testing is the diagnostic standard for the detection of allergic contact dermatitis. The present guidelines are aimed at residents and board-certified physicians in the fields of dermatology and allergology as well as other medical specialties involved in establishing the indication for patch testing and its execution in patients with contact dermatitis and other forms of delayed-type hypersensitivity. The target audience also includes other health care providers and insurance funds. Based on a systematic literature search and a formal consensus process (S3), the guidelines were developed by dermatologists in collaboration with pediatricians, occupational medicine physici…

Occupational Medicinemedicine.medical_specialtyConsensusMEDLINETarget audienceGuidelines as TopicDermatologyPatch testingOccupational medicineImmunocompromised Host030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePregnancyHealth caremedicineHumansHypersensitivity DelayedPediatriciansChildAllergic contact dermatitisbusiness.industryAllergensPatch Testsmedicine.diseaseTest (assessment)Family medicineDermatitis Allergic ContactFemaleNursing StaffbusinessContact dermatitisDermatologistsJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Prophylactic cranial irradiation in stage IV small cell lung cancer

2019

Background: Due to conflicting results between major trials the role of prophylactic cranial irradiation (PCI) in stage IV small cell lung cancer (SCLC) is controversial.Methods: We obtained a list of 13 European experts from both the European Society for Therapeutic Radiation Oncology (ESTRO) and the International Association for the Study of Lung Cancer (IASLC). The strategies in decision making for PCI in stage IV SCLC were collected. Decision trees were created representing these strategies. Analysis of consensus was performed with the objective consensus methodology.Results: The factors associated with the recommendation for the use of PCI included the fitness of the patient, young age…

OncologyMaleESTRO; Expert opinion; IASLC; PCI; Small cell lung cancer; Stage IV; Hematology; Oncology; Radiology Nuclear Medicine and ImagingLung Neoplasmsmedicine.medical_treatmentMedizin030218 nuclear medicine & medical imaging0302 clinical medicineQUALITY-OF-LIFENuclear Medicine and ImagingESTRO610 Medicine & healthStage IVHematologyBrain NeoplasmsRadiation OncologistsPCIHematologyMiddle AgedProgression-Free SurvivalExpert opinion030220 oncology & carcinogenesisFemaleTRIALNon small cellRadiologyAdultmedicine.medical_specialtyDecision Making03 medical and health sciencesInternal medicinemedicineHumansIASLCRadiology Nuclear Medicine and imagingLung cancerAgedNeoplasm StagingChemotherapySmall cell lung cancerbusiness.industryPatient Selectionmedicine.diseaseONCOLOGYSmall Cell Lung CarcinomaYoung ageConventional PCIProphylactic cranial irradiationCranial IrradiationbusinessStage ivRadiotherapy and Oncology
researchProduct

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)

2016

The European Society for Medical Oncology (ESMO) is one of the leading societies of oncology professionals in the world. Approximately 30% of the 13 000 ESMO members are below the age of 40 and thus meet the society's definition of young oncologists (YOs). ESMO has identified the training and development of YOs as a priority and has therefore established a comprehensive career development programme. This includes a leadership development programme to help identify and develop the future leaders in oncology. Well-trained and highly motivated future generations of multidisciplinary oncologists are essential to ensure the optimal evolution of the field of oncology with the ultimate goal of pro…

Oncologymedicine.medical_specialtyCancer ResearchReviewFellowshipExecutive boardMultidisciplinary approachInternal medicineJournal ArticleMedicine15061507Leadership developmentbusiness.industryLeadership ProgrammeGénéralitésESMOTraining and developmentYoung OncologistsOncologyESMO; Fellowship; Leadership Programme; Preceptorship; Young OncologistsPreceptorshipPortfoliobusinessCareer developmentESMO; Fellowship; Leadership Programme; Preceptorship; Young Oncologists; Cancer Research; Oncology
researchProduct

Can ‘Fellow of the European Board of Ophthalmology Subspecialty Diploma in Glaucoma,’ a subspecialty examination on glaucoma induce the qualification…

2016

From 2015, the examination of Fellow of the European Board of Ophthalmology Subspecialty Diploma in Glaucoma (FEBOS-Glaucoma) was launched by the European Board of Ophthalmology (EBO) in cooperation with the European Glaucoma Society (EGS). This opinion aims at disclosing the background of the examination, prerequisite to the examination, and the value of the FEBOS-Glaucoma diploma.

Organes des sensgenetic structures020205 medical informaticsSpecialty boardophtalmologielcsh:MedicineGlaucoma02 engineering and technology0302 clinical medicineSpecialty Boards0202 electrical engineering electronic engineering information engineeringPractice Patterns Physicians'ComputingMilieux_MISCELLANEOUSSocieties Medicallcsh:LC8-6691Ophthalmologists3. Good healthClinical PracticeEurope[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansGeneral Health ProfessionsClinical CompetenceCurriculumClinical competenceSpecializationEducational measurementmedicine.medical_specialtyOpinionSensory OrganseducationMédecine humaine et pathologieSubspecialtyEducation03 medical and health sciencesOphthalmologymedicineHumans[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansFellowships and Scholarshipslcsh:Special aspects of educationbusiness.industrylcsh:RInternship and ResidencyGlaucomamedicine.diseaseeye diseasesOphthalmologyEducation Medical Graduate030221 ophthalmology & optometryOptometryHuman health and pathologysense organsEducational MeasurementbusinessJournal of Educational Evaluation for Health Professions
researchProduct

Knowledge of alpha-1 deficiency and primary ciliary dyskinesia by medical students and health professionals

2016

Background: Under-diagnosis and delayed diagnosis are common features in rare diseases, which have negative effects on the patients9 prognosis. A possible explanation could be lack of awareness and education of the health professionals involved in the managements of these patients. Alpha-1-antitrypsin deficiency (AATD) and primary ciliary dyskinesia (DCP) are under-diagnosed rare diseases showing a median diagnosis delay of five to ten years. Methods: A survey was undertaken in paediatricians (general, paediatric pulmonologists and paediatric gastroenterologist) and medical school students to assess their knowledge on AATD and PCD. Results: A total of 624 surveys on AATD and 457 on PCD were…

Paediatric gastroenterologistTime delaysPediatricsmedicine.medical_specialtyHealth professionalsbusiness.industryeducationMedical schoolAlpha (ethology)Delayed diagnosismedicine.diseaseMedicinebusinessPulmonologistsPrimary ciliary dyskinesia7.6 Paediatric Respiratory Epidemiology
researchProduct

Recommendations for neonatologists and pediatricians working in first level birthing centers on the first communication of genetic disease and malfor…

2021

Abstract Background Genetic diseases are chronic conditions with relevant impact on the lives of patients and their families. In USA and Europe it is estimated a prevalence of 60 million affected subjects, 75% of whom are in developmental age. A significant number of newborns are admitted in the Neonatal Intensive Care Units (NICU) for reasons different from prematurity, although the prevalence of those with genetic diseases is unknown. It is, then, common for the neonatologist to start a diagnostic process on suspicion of a genetic disease or malformation syndrome, or to make and communicate these diagnoses. Many surveys showed that the degree of parental satisfaction with the methods of c…

ParentsRecommendations.Genetic diseaseDiseaseRecommendationsPediatricsCommunication of diagnosis0302 clinical medicineNeonatologistsPregnancyPrenatal DiagnosisNeonatalMedicine030212 general & internal medicineMedical diagnosisScientificSettore MED/38Intensive Care UnitsItalyGenetic DiseasesFemaleSocieties Scientificmedicine.medical_specialtyConsensusBest practiceConsensuGenetic CounselingTruth DisclosureBirthing CentersRJ1-570Defensive medicineCongenital Abnormalities03 medical and health sciences030225 pediatricsIntensive careIntensive Care Units NeonatalHumansNeonatologyPediatriciansCommunication of diagnosiModalitiesbusiness.industryResearchGenetic Diseases InbornBioethicsInbornFamily medicinebusinessMalformation syndromeSocieties
researchProduct